ReviewBlood research2014
Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants.
Review in Blood research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
44 citing papers in PubMed, 1 synthesis or guideline pooled it, 101 citations in OpenAlex.
- Pediatric APS: State of the Art.Current rheumatology reports · 2020Pooled it
- A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure.Journal of thrombosis and thrombolysis · 2017Trial
- Paracentral acute middle maculopathy following trabeculectomy: A case report and review of the literature.American journal of ophthalmology case reports · 2026Article
- Persistent hypercoagulability and acute limb ischemia post COVID-19.Journal of vascular surgery cases and innovative techniques · 2025Article
- Review
- The Construction of a Molecular Model for the Ternary Protein Complex of Intrinsic Coagulation Pathway Factors Provides Novel Insights for the Pathogenesis of Cross-Reactive Material Positive Coagulation Factor Mutations.International journal of molecular sciences · 2025Article
- Massive Central Pulmonary Embolism with Riding Embolus and Concomitant Aortic Arch Embolism-Should We Diagnose Patients Earlier for Blood Clotting Disorders? Case Report.Journal of cardiovascular development and disease · 2025Article
- Review
- A Compact Differential Dynamic Microscopy-based Device (cDDM): An Approach Tool for Early Detection of Hypercoagulable State in Transfusion-Dependent-β-Thalassemia Patients.ACS applied bio materials · 2024Article
- Thromboembolism in Children: Unveiling Risk-Factors.Indian journal of pediatrics · 2024Article
- Ischaemic stroke in a patient with non-valvular atrial fibrillation (NVAF) despite non-vitamin K oral anticoagulant (NOAC) therapy.BMJ case reports · 2024Article
- Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.Biomedicines · 2023Review
- Cocaine-Induced Ascending Aortic Thrombus.Cureus · 2023Article
- Clinical lesson to not overlook venous thrombosis: a case of primary antiphospholipid syndrome.BMJ case reports · 2023Article
- To Bleed or Not to Bleed.Cureus · 2023Article
- Association between Factor-V Leiden and occurrence of acute myocardial infarction using a large NIS database.American journal of blood research · 2023Article
- Association of arterial stiffness with a prothrombotic state in uncomplicated nondiabetic hypertensive patients.Frontiers in cardiovascular medicine · 2023Article
- Neurologic and Thrombotic Complications in the Setting of Chronic Nitrous Oxide Abuse.Case reports in medicine · 2023Article
- Adrenal infarction secondary to methamphetamine use: a case report and review of the literature.Journal of medical case reports · 2022Review
- Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series.Pediatric rheumatology online journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypercoagulability can result from a variety of inherited and, more commonly, acquired conditions. Testing for the underlying cause of thrombosis in a patient is complicated both by the number and variety of clinical conditions that can cause hypercoagulability as well as the many potential assay interferences. Using an algorithmic approach to hypercoagulability testing provides the ability to tailor assay selection to the clinical scenario. It also reduces the number of unnecessary tests performed, saving cost and time, and preventing potential false results. New oral anticoagulants are powerful tools for managing hypercoagulable patients; however, their use introduces new challenges in terms of test interpretation and therapeutic monitoring. The coagulation laboratory plays an essential role in testing for and treating hypercoagulable states. The input of laboratory professionals is necessary to guide appropriate testing and synthesize interpretation of results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.